Wells Fargo & Company Issues Positive Forecast for Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price

Sabra Healthcare REIT (NASDAQ:SBRA) had its price target hoisted by Wells Fargo & Company from $21.00 to $22.00 in a research report sent to investors on Thursday,Benzinga reports. The brokerage currently has an overweight rating on the real estate investment trust’s stock.

A number of other research analysts have also recently weighed in on the stock. Weiss Ratings upgraded shares of Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Wednesday, March 18th. Truist Financial increased their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a report on Friday, March 13th. Citigroup boosted their target price on Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a research note on Wednesday, February 18th. Jefferies Financial Group reiterated a “buy” rating and set a $22.00 price target on shares of Sabra Healthcare REIT in a research note on Monday, December 15th. Finally, Citizens Jmp lifted their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock a “market outperform” rating in a report on Wednesday, February 18th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $22.00.

Sabra Healthcare REIT Stock Down 1.1%

SBRA stock opened at $19.63 on Thursday. The stock’s fifty day simple moving average is $19.78 and its two-hundred day simple moving average is $19.07. The company has a current ratio of 4.29, a quick ratio of 4.29 and a debt-to-equity ratio of 0.90. Sabra Healthcare REIT has a 1-year low of $15.75 and a 1-year high of $21.07. The stock has a market cap of $4.95 billion, a P/E ratio of 30.67, a P/E/G ratio of 1.58 and a beta of 0.64.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.26). The business had revenue of $201.35 million for the quarter, compared to analysts’ expectations of $201.97 million. Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The company’s revenue for the quarter was up 16.2% compared to the same quarter last year. During the same period in the prior year, the business earned $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Analysts expect that Sabra Healthcare REIT will post 1.45 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 27th. Investors of record on Friday, February 13th were issued a $0.30 dividend. The ex-dividend date of this dividend was Friday, February 13th. This represents a $1.20 annualized dividend and a yield of 6.1%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 187.50%.

Institutional Investors Weigh In On Sabra Healthcare REIT

Hedge funds and other institutional investors have recently bought and sold shares of the business. Principal Financial Group Inc. boosted its holdings in shares of Sabra Healthcare REIT by 21.6% in the fourth quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock worth $472,617,000 after acquiring an additional 4,431,897 shares during the period. Lasalle Investment Management Securities LLC bought a new stake in shares of Sabra Healthcare REIT during the 4th quarter valued at $66,938,000. Engineers Gate Manager LP lifted its holdings in Sabra Healthcare REIT by 3,190.3% during the 2nd quarter. Engineers Gate Manager LP now owns 3,179,303 shares of the real estate investment trust’s stock worth $58,626,000 after purchasing an additional 3,082,677 shares in the last quarter. Norges Bank purchased a new stake in Sabra Healthcare REIT during the 4th quarter worth about $57,945,000. Finally, Sumitomo Mitsui Trust Group Inc. boosted its stake in Sabra Healthcare REIT by 1,019.8% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,005,374 shares of the real estate investment trust’s stock worth $56,922,000 after purchasing an additional 2,736,993 shares during the period. Institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.